Allied Academies Publication is an amalgamation of several esteemed academic and scientific associations known for promoting scientific temperament. Established in the year 1997, Andrew John Publishing Group is a specialized Medical publisher that operates in collaboration with the association and societies. This publishing house has been built on the base of esteemed academic and research institutions including The College of Audiologists and Speech Language Pathologists of Ontario(CASLPO), The Association for Public Safety Communications Officials of Canada (APCO), The Canadian Vascular Access Association (CVAA), The Canadian Society of Internal Medicine (CSIM), The Canadian Hard of Hearing Association (CHHA), Sonography Canada, Canadian Association of Pathologists (CAP-ACP).
Digestive Diseases 2018 is all about providing a resourceful and knowledgeable arena for the participants in the field of Gastroenterology and Metabolic Diseases. We strive to provide a perfect stage to share knowledge and experiences and encourage people to carry out effective researches and works to combat against the global threat. We have research expertise and many specialized Doctors from different parts of the world coming to share their latest research works in the field of Digestive Diseases. And to inspire the young minds we are glad to present a special category - The Young Researcher Forum (YRF).
Alliedacademies Welcomes all the speakers, sponsor’s and other research expertise from all over the world to the “World Congress on Digestive and Metabolic Diseases”, which is going to be held during September 21-22, 2018 in Vancouver, Canada. We are very much honored to invite you all to exchange and share your views in Digestive and Metabolic Diseases.
Allied Academics Organizes Digestive Diseases 2018 along with 300+ Conferences across USA, Europe & Asia every year with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities as editorial board members.
We invite you to join us at the Digestive Diseases-2018, where you will be sure to have a meaningful experience with Doctors, Physicians, Professors, and Students from around the world. All members of the Digestive Diseases -2018 Organizing committee look forward to meeting you in Vancouver, Canada.
Sessions / Tracks
Track - 1: Basic Science
Digestive diseases are amid the leading fountainhead of doctor visits, hospitalizations, and abnormality in the United States each year. These conditions span a wide spectrum of disorders that affect the gastrointestinal (GI) tract, liver, gallbladder, and pancreas, as well as obesity and other nutrition-related disorders. Some digestive diseases, such as celiac disease, can be triggered by the body’s reaction to certain foods. Digestive diseases can cause serious complications ranging from severe pain to elevated risk of cancer to liver failure. The metabolic syndrome (MetS) is a crucial and mounting public-health and clinical challenge worldwide. MetS confers a 5-fold increase in the risk of type 2 diabetes mellitus (T2DM) and 2-fold the risk of developing cardiovascular disease (CVD) over the next 5 to 10 years. Further, patients with the MetS are at 2- to 4-fold increased risk of stroke, a 3- to 4-fold increased risk of myocardial infarction (MI), and 2-fold the risk of dying from such an event compared with those without the syndrome regardless of a previous history of cardiovascular events
Track - 2: Biliary Tract Disease
Biliary Tract Diseases occurs when bile ducts in liver are slowly demolished, When bile duct are choked or destroyed, symptoms like yellowing of the skin (jaundice) or eyes (icterus) due to formation of waste product called bilirubin, Itching (not limited to one particular area; may be worse at night or in warm weather),Light brown urine, Fatigue, Weight loss ,fever or night sweats.
Bile Duct Cancer (Cholangiocarcinoma)
Track - 3: Colorectal Diseases
The Disarray of lower gastrointestinal tract can be throbbing, abashing and even life-threatening. The root cause can be immensely hard to spot. The evidence of colon and rectal disease is nearly identical to other diseases, There is a prospective for misdiagnosis and mistreatment. Also study shows that patient treated by colon and rectal surgeons are likely to have colorectal cancer. Colorectal cancer annually hits about 140,000 people and causes 60,000 deaths, but is potentially curable if detected in its early stages. More than 90 percent of patients are over 40, at which point the risk of contracting the disease doubles every ten years.
Irritable Bowel Syndrome (IBS)
Track - 4: Functional GI and Motility Disorders
Management of GI motility
Development of novel tools in motility
Gastrointestinal Motility disorders
Track - 5: Inflammatory Bowel Diseases
Inflammatory bowel disease (IBD) repesents an association of intestinal disorders that engender prolonged inflammation of the digestive tract. These are of two types: Ulcerative colitis and Crohn's disease. Ulcerative colitis causes long-lasting inflammation and sores (ulcers) in the innermost lining of large intestine (colon) and rectum.
Future IBD therapies
Understanding the use of IL12/IL23 targeted Biologics
Treatment of moderate to severe IBD with anti-TNF
Biologics and Immunomodulators
Optimizing adhesion molecule-based therapies
Track - 6: Liver Diseases
The liver accomplishes many complex functions in the body. Liver failure can happen suddenly (acute liver failure) as a result of viral hepatitis, drug-induced injury or infection. Liver failure can also be the end result of a long-term problem. It is also considered as a gland because among of its many functions, it makes and secretes bile. Alcohol abuse is the most common cause of liver disease in North America. Alcohol is directly toxic to liver cells and can cause liver inflammation, referred to as alcoholic hepatitis. In chronic alcohol abuse, fat accumulation occurs in liver cells affecting their ability to function. Cirrhosis is a final -stage of liver disease.
Hepatic Medicine: Evidence and Research
Cirrhosis and Its Complications
Track - 7: Microbiome in Gastrointestinal and Liver Diseases
ERCP (Endoscopic Retrograde Cholangio-Pancreatography)
Computed tomography (CT)
Sphincter of Oddi Dysfunction
Track - 8: Obesity and Nutrition
Adjustable Gastric Banding
Gastric Bypass Surgery
Implantable Maestro System
Gastric Plication Surgery
Track - 9: Pancreatic Diseases
Track - 10: Pediatric GI
The Division of Pediatric Gastroenterology is perpetrated to provide the highest quality medical care and state-of-the-art techniques in the evaluation and treatment of gastrointestinal, liver and nutritional disorders. Pediatric Gastroenterology constitutes one of the broadest pediatric subspecialities. Realm of interest includes luminal conditions, hepatology, pancreatic diseases, and nutritional disorders, along with interactions between these (such as luminal disorders disrupting nutrition). Furthermore, pediatric gastroenterology services regularly intersect with almost all other subspecialities. Pediatric gastroenterology faces many different challenges. These include the type and character of the conditions cared for, the changing patterns of conditions over time, new developments and technologies, and expanding knowledge.
Feeding tube placement (PEG)
Breathe hydrogen analysis for lactose intolerance
Small bowel transplantation
Track - 11: Gastrointestinal Oncology
Gastric cancer is an belligerent disease that continues to have a formidable impact on global health. Despite an overall decline in incidence over the last several decades, gastric cancer remains the fourth most common type of cancer and is the second leading cause of cancer-related death worldwide accounting for 10% of global cancer mortalities. Despite the progress made in recent years, the prognosis for patients with advanced-stage GC remains poor. The last several decades have demonstrated a gradual decline in the rates of gastric cancer in most populations and across subtypes. However, whereas most gastric tumors are declining in incidence, tumors of the gastric cardia and gastroesophageal junction are becoming more frequent and there is a trend of rising incidence of noncardia gastric cancer among Americans between 25 and 39 years of age and in the same age group in other western countries. The incidence rate in men is double that of women and incidence increases with age.
Gastrointestinal carcinoid tumor
Track - 12: Stomach and Small Bowel Disorders
Track - 13: Technologies and Procedural Innovations
In contemporary years,
there has been prodigious improvement in the gastrointestinal and hepatology
space. These include alteration in colorectal cancer screening, capsule
endoscopy, cures for hepatitis C and new biologic therapies, among many others.
While these developments have been exciting and moved the field forward. Today's healthcare delivery model centers are around the 15 to 30 minute clinic visit, yet patients spend 99.9 percent of their lives outside of the clinic either at home, at work or at play. New digital choledochoscopes have vastly improved diagnostic and therapeutic capabilities within the bile and pancreatic duct. Confocal endomicroscopy now allows us to perform microscopic evaluation of living tissues, improving targeted biopsies in Barrett's esophagus and aiding in the evaluation of bile duct strictures and pancreatic cysts. Similarly, technological advances in endoscopic ultrasound, optical coherence tomography and spectroscopy hold great promise for improving diagnostic and therapeutic capabilities for gastrointestinal disease.
Natural Orifice Translumenal Endoscopic Surgery
GI endoscopy and video capsule endoscopy
Screening and therapeutic colonoscopy
Sphincter sparing surgery for colorectal cancer
Digestive Diseases deals with bioscience known with the digestive tube and therefore the adornment organs of assimilation (from the mouth to the anus). A little of the conditions treated below this forte incorporate but don't seem to be restricted to Crohn's infection, esophageal reflux malady (GERD), fiery within illness, dangerous tempered entrail disorder, ulceration sickness, celiac upset, colon illness, acid reflux, internal organ growth, redness, and inflammatory bowel disease. whereas an oversized variety of those ailments area unit incessant and should be dealt therapeutically, additional comprehensive and characteristic methodologies area unit being utilized all the additional abundant of the time to counteract and administrate canal scatters. Various human services suppliers area unit providing stress management, a healthy diet, and exercise to manage and forestall facet effects. As per the new applied mathematics measurement report, "Gastrointestinal Diseases Market, by Drug class (Antacid and Anti-Ulcer hymenopterous insect, rat Anti-provocative, Antiemetic, Anti-looseness of the bowels and different rat Therapeutics) - World Revenue, Trends, Growth, Share, Size and Forecast to 2022", the worldwide canal maladies market can come through USD 19.79 billion by 2022, developing at a CAGR of 2.3% amid the conjecture time frame.
Future scope :